De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism
- PMID: 21237447
- DOI: 10.1016/j.biopsych.2010.11.015
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism
Abstract
Background: Little is known about the genetics of nonsyndromic intellectual disability (NSID). Recently, we reported de novo truncating mutations in the SYNGAP1 gene of 3 of 94 NSID cases, suggesting that its disruption represents a common cause of autosomal dominant NSID.
Methods: To further explore the involvement of SYNGAP1 in NSID, we sequenced its exons and intronic boundaries in 60 additional sporadic cases of NSID, including 30 patients with autism spectrum disorders (ASD) and 9 with epilepsy, and in 380 control individuals.
Results: We identified de novo out-of-frame deletions in two patients with NSID and mild generalized epilepsy (c.2677delC/p.Q893RfsX184 and c.321_324delGAAG/p. K108VfsX25) and a de novo splicing mutation (c.2294 + 1G>A), which results in the creation of a premature stop codon, in a patient with NSID and autism. No splicing or truncating mutations were found in control subjects.
Conclusions: We provide evidence that truncating mutations in SYNGAP1 are common in NSID and can be also associated with autism.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12. Hum Mutat. 2013. PMID: 23161826
-
De novo autosomal dominant mutation in SYNGAP1.Autism Res. 2011 Apr;4(2):155-6. doi: 10.1002/aur.198. Autism Res. 2011. PMID: 21480541 Review. No abstract available.
-
De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy.Ann Neurol. 2009 Jun;65(6):748-53. doi: 10.1002/ana.21625. Ann Neurol. 2009. PMID: 19557857
-
A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA).Epilepsia. 2011 Dec;52(12):e190-3. doi: 10.1111/j.1528-1167.2011.03304.x. Epub 2011 Nov 2. Epilepsia. 2011. PMID: 22050443
-
Could autism with mental retardation result from digenism and frequent de novo mutations?World J Biol Psychiatry. 2009;10(4 Pt 3):1030-6. doi: 10.1080/15622970802627455. World J Biol Psychiatry. 2009. PMID: 19160128 Review.
Cited by
-
Phosphorylation of synaptic GTPase-activating protein (synGAP) by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and cyclin-dependent kinase 5 (CDK5) alters the ratio of its GAP activity toward Ras and Rap GTPases.J Biol Chem. 2015 Feb 20;290(8):4908-4927. doi: 10.1074/jbc.M114.614420. Epub 2014 Dec 22. J Biol Chem. 2015. PMID: 25533468 Free PMC article.
-
Add-on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy.Epilepsia Open. 2020 Jul 1;5(3):496-500. doi: 10.1002/epi4.12411. eCollection 2020 Sep. Epilepsia Open. 2020. PMID: 32913957 Free PMC article.
-
Rapid dispersion of SynGAP from synaptic spines triggers AMPA receptor insertion and spine enlargement during LTP.Neuron. 2015 Jan 7;85(1):173-189. doi: 10.1016/j.neuron.2014.12.023. Neuron. 2015. PMID: 25569349 Free PMC article.
-
Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses.Cell. 2012 Nov 9;151(4):709-723. doi: 10.1016/j.cell.2012.08.045. Cell. 2012. PMID: 23141534 Free PMC article.
-
Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing.Front Genet. 2024 Aug 30;15:1352480. doi: 10.3389/fgene.2024.1352480. eCollection 2024. Front Genet. 2024. PMID: 39280100 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
